Advanced
  Home Compare Reports

Comparison with Similar Reports

Infusion Pump Market by Product [Accessories (Dedicated, Non-dedicated), Devices (Volumetric, Insulin, Syringe, Ambulatory)], Technology (Traditional,...

Publisher:        MarketsandMarkets

# of Pages:        415

Rating: 

1 User License $4,950

Publication Date:  July, 2021

Price:       $4,950 / User License




1 INTRODUCTION 48
1.1 OBJECTIVES OF THE STUDY 48
1.2 MARKET DEFINITION 48
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 49
1.3 MARKET SCOPE 50
1.3.1 MARKETS COVERED 50
1.3.2 YEARS CONSIDERED FOR THE STUDY 51
1.3.3 CURRENCY 51
1.4 STAKEHOLDERS 52
1.5 SUMMARY OF CHANGES 53
2 RESEARCH METHODOLOGY 54
2.1 RESEARCH APPROACH 54
2.2 RESEARCH METHODOLOGY DESIGN 54
FIGURE 1 INFUSION PUMPS MARKET: RESEARCH DESIGN 54
2.2.1 SECONDARY RESEARCH 55
2.2.1.1 Key data from secondary sources 56
2.2.2 PRIMARY DATA 57
FIGURE 2 PRIMARY SOURCES 57
2.2.2.1 Key data from primary sources 58
2.2.2.2 Key industry insights 59
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 59
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE
AND DEMAND-SIDE PARTICIPANTS 60
2.3 MARKET SIZE ESTIMATION 60
FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 61
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: BECTON, DICKINSON AND COMPANY 61
FIGURE 7 REVENUE ANALYSIS OF THE TOP SIX COMPANIES: INFUSION PUMPS MARKET (2020) 62
FIGURE 8 DEMAND-SIDE ANALYSIS: INFUSION PUMPS MARKET 63
FIGURE 9 DEMAND-SIDE AND SUPPLY-SIDE ANALYSIS: INSULIN PUMPS MARKET 64
FIGURE 10 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE INFUSION PUMPS MARKET (2021–2026) 65
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 65
FIGURE 12 TOP-DOWN APPROACH 66
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 67
FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY 67
 
2.5 MARKET SHARE ANALYSIS 68
2.6 ASSUMPTIONS FOR THE STUDY 68
2.7 RISK ASSESSMENT 69
TABLE 1 RISK ASSESSMENT: INFUSION PUMPS MARKET 69
2.8 LIMITATIONS 69
2.8.1 METHODOLOGY-RELATED LIMITATIONS 69
2.8.2 SCOPE-RELATED LIMITATIONS 69
3 EXECUTIVE SUMMARY 70
FIGURE 14 INFUSION PUMPS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 70
FIGURE 15 INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 71
FIGURE 16 DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 71
FIGURE 17 NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 72
FIGURE 18 INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 73
FIGURE 19 INFUSION PUMP DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 73
FIGURE 20 INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2021 VS. 2026 (USD MILLION) 74
FIGURE 21 INFUSION PUMPS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION) 75
FIGURE 22 INFUSION PUMPS MARKET, BY SETTING, 2021 VS. 2026 (USD MILLION) 76
FIGURE 23 GEOGRAPHIC SNAPSHOT: INFUSION PUMPS MARKET 76
4 PREMIUM INSIGHTS 78
4.1 INFUSION PUMPS MARKET OVERVIEW 78
FIGURE 24 GROWING PREVALENCE OF CHRONIC DISEASES TO DRIVE THE GROWTH OF THE INFUSION PUMPS MARKET 78
4.2 ASIA PACIFIC: INFUSION PUMPS MARKET, BY APPLICATION AND COUNTRY 79
FIGURE 25 CHINA DOMINATED THE APAC INFUSION PUMPS MARKET IN 2021 79
4.3 INFUSION PUMPS MARKET: GEOGRAPHIC MIX 80
FIGURE 26 INDIA & CHINA TO WITNESS THE HIGHEST GROWTH IN THE INFUSION PUMPS MARKET DURING THE FORECAST PERIOD 80
5 MARKET OVERVIEW 81
5.1 MARKET DYNAMICS 81
FIGURE 27 INFUSION PUMPS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 81
5.1.1 MARKET DRIVERS 82
5.1.1.1 Rising demand for ambulatory infusion pumps in home care settings 82
5.1.1.2 Increasing incidence of chronic diseases along with the rapid growth of the geriatric population 82
FIGURE 28 US: NUMBER OF PEOPLE WITH CHRONIC CONDITIONS, 1
995–2030 (MILLION INDIVIDUALS) 83
FIGURE 29 GLOBAL CANCER INCIDENCE, 2015–2040 84
FIGURE 30 ESTIMATED DIABETIC POPULATION, BY REGION, 2019 VS. 2030 VS. 2040 84
5.1.1.3 Growing number of surgical procedures performed 85
5.1.1.4 Increasing number of ICU beds in countries with a high
prevalence of COVID-19 85
TABLE 2 MARKET DRIVERS: IMPACT ANALYSIS 86
5.1.2 MARKET RESTRAINTS 86
5.1.2.1 Product recalls 86
TABLE 3 INDICATIVE LIST OF PRODUCT RECALLS FOR INFUSION PUMPS
(2017–JUNE 2021) 87
5.1.2.2 Stringent regulatory requirements for new products 89
5.1.2.3 Increasing adoption of refurbished and rental infusion pumps 89
TABLE 4 MARKET RESTRAINTS: IMPACT ANALYSIS 90
5.1.3 MARKET OPPORTUNITIES 90
5.1.3.1 High growth opportunities in emerging countries 90
TABLE 5 RISING INCOME LEVELS IN EMERGING COUNTRIES 91
5.1.3.2 Growing adoption of specialty infusion systems 91
TABLE 6 MARKET OPPORTUNITIES: IMPACT ANALYSIS 92
5.1.4 MARKET CHALLENGES 92
5.1.4.1 Increasing incidence of medication errors and lack of wireless connectivity in most hospitals 92
TABLE 7 MARKET CHALLENGES: IMPACT ANALYSIS 92
5.2 INDUSTRY TRENDS 93
5.2.1 SMART PUMP-EMR INTEROPERABILITY 93
TABLE 8 RECENT DEVELOPMENTS IN SMART PUMP-EMR INTEROPERABILITY 93
5.2.2 GROWING FOCUS ON THE DEVELOPMENT OF HYBRID CLOSED-LOOP SYSTEMS/ARTIFICIAL PANCREAS DEVICE SYSTEMS 94
TABLE 9 HYBRID CLOSED-LOOP SYSTEMS: CURRENT MARKET SCENARIO 94
5.2.3 GROWING FOCUS ON SPECIALTY PUMPS & ADDED ADVANCED FEATURES 95
5.3 PRICING ANALYSIS 95
TABLE 10 ASP OF INFUSION PUMP DEVICES (2019) 96
TABLE 11 ASP OF NON-DEDICATED ACCESSORIES & CONSUMABLES (2019) 96
5.4 VALUE CHAIN ANALYSIS 96
FIGURE 31 INFUSION PUMPS MARKET: VALUE CHAIN ANALYSIS 97
5.5 SUPPLY CHAIN ANALYSIS 97
FIGURE 32 INFUSION PUMPS MARKET: SUPPLY CHAIN ANALYSIS 98
5.6 ECOSYSTEM MARKET MAP 98
FIGURE 33 INFUSION PUMPS MARKET: ECOSYSTEM MARKET MAP 99
5.7 PORTER’S FIVE FORCES ANALYSIS 99
TABLE 12 PORTER’S FIVE FORCES ANALYSIS 100
5.7.1 THREAT FROM NEW ENTRANTS 100
5.7.2 THREAT FROM SUBSTITUTES 101
5.7.3 BARGAINING POWER OF SUPPLIERS 101
5.7.4 BARGAINING POWER OF BUYERS 101
5.7.5 COMPETITIVE RIVALRY 102
5.8 REGULATORY ANALYSIS 102
TABLE 13 STRINGENCY OF REGULATIONS FOR INFUSION PUMPS, BY REGION 102
5.8.1 NORTH AMERICA 102
5.8.1.1 US 102
TABLE 14 INFUSION PUMP PRODUCT CODE 103
TABLE 15 US FDA: MEDICAL DEVICE CLASSIFICATIONS 103
TABLE 16 US: REGULATORY PROCESS FOR MEDICAL DEVICES 104
5.8.1.2 Canada 104
FIGURE 34 CANADA: APPROVAL PROCESS OF CLASS III MEDICAL DEVICES 105
5.8.2 EUROPE 105
FIGURE 35 EUROPE: CE MARK APPROVAL PROCESS FOR CLASS III MEDICAL DEVICES 105
5.8.3 APAC 106
5.8.3.1 Japan 106
TABLE 17 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 106
5.8.3.2 China 106
TABLE 18 CHINA: CFDA CLASSIFICATION OF MEDICAL DEVICES 107
5.8.3.3 India 107
5.8.4 LATIN AMERICA 108
FIGURE 36 LATIN AMERICA: REGULATORY SCENARIO 108
5.8.4.1 Brazil 108
FIGURE 37 BRAZIL: REGULATORY PROCESS FOR MEDICAL DEVICES 109
TABLE 19 BRAZIL: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 109
5.8.4.2 Mexico 110
FIGURE 38 MEXICO: REGULATORY PROCESS FOR MEDICAL DEVICES 110
TABLE 20 MEXICO: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 111
5.9 IMPACT OF COVID-19 ON THE INFUSION PUMPS MARKET 111
FIGURE 39 IMPACT OF COVID-19 ON THE INFUSION PUMP DEVICES MARKET 113
5.10 PATENT ANALYSIS 113
5.10.1 PATENT PUBLICATION TRENDS FOR INFUSION PUMPS 113
FIGURE 40 PATENT PUBLICATION TRENDS (2011–JULY 2021) 113
5.10.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 114
FIGURE 41 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR INFUSION PUMP PATENTS (JANUARY 2011–JUNE 2021) 114
FIGURE 42 TOP APPLICANT COUNTRIES/REGIONS FOR INFUSION PUMP PATENTS (JANUARY 2011–JUNE 2021) 115
5.11 TECHNOLOGY ANALYSIS 115
5.11.1 KEY TECHNOLOGIES 115
5.11.1.1 Flow generation 115
5.11.1.2 Flow control 116
5.11.2 ADJACENT TECHNOLOGIES 116
5.11.2.1 Embedded software 116
5.11.2.2 Sensing technology 116
5.11.3 COMPLEMENTARY TECHNOLOGIES 116
5.11.3.1 Dose error reduction systems 116
5.11.3.2 Wireless connectivity 117
5.12 TRADE ANALYSIS 117
TABLE 21 WORLD EXPORT DATA OF INFUSION PUMPS FOR 2019 117
TABLE 22 TRADE DATA ANALYSIS OF INFUSION PUMP IMPORTS TO INDIA 120
6 INFUSION PUMPS MARKET, BY PRODUCT 122
6.1 INTRODUCTION 123
TABLE 23 INFUSION PUMPS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 123
6.2 IMPACT OF COVID-19 ON THE INFUSION PUMPS MARKET, BY PRODUCT 123
6.3 ACCESSORIES & CONSUMABLES 124
TABLE 24 MAJOR INFUSION PUMP ACCESSORIES & CONSUMABLES AVAILABLE IN THE MARKET 124
TABLE 25 INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 126
TABLE 26 INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 127
6.3.1 DEDICATED ACCESSORIES & CONSUMABLES 127
TABLE 27 DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 128
TABLE 28 DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 128
6.3.1.1 Volumetric infusion pumps 129
6.3.1.1.1 High adoption of volumetric infusion pumps and related accessories to deliver large volumes of medications and nutrients to patients in hospitals to drive market growth 129
TABLE 29 DEDICATED ACCESSORIES & CONSUMABLES MARKET FOR VOLUMETRIC INFUSION PUMPS, BY COUNTRY, 2019–2026 (USD MILLION) 129
6.3.1.2 Insulin pumps 130
6.3.1.2.1 Rising demand for insulin pumps for home healthcare to support the growth of this market segment 130
TABLE 30 DEDICATED ACCESSORIES & CONSUMABLES MARKET FOR INSULIN PUMPS, BY COUNTRY, 2019–2026 (USD MILLION) 130
6.3.1.3 Enteral infusion pumps 131
6.3.1.3.1 Preference for low-cost, non-dedicated accessories in low-income countries to hamper market growth during the forecast period 131
TABLE 31 DEDICATED ACCESSORIES & CONSUMABLES MARKET FOR ENTERAL INFUSION PUMPS, BY COUNTRY, 2019–2026 (USD MILLION) 131
6.3.1.4 Syringe infusion pumps 132
6.3.1.4.1 Adoption of dedicated syringe pump accessories is high in developed countries—a key factor driving market growth 132
TABLE 32 DEDICATED ACCESSORIES & CONSUMABLES MARKET FOR SYRINGE INFUSION PUMPS, BY COUNTRY, 2019–2026 (USD MILLION) 132
6.3.1.5 Ambulatory infusion pumps 133
6.3.1.5.1 Growth in the home healthcare market is driving the demand for ambulatory infusion pump accessories & consumables 133
TABLE 33 DEDICATED ACCESSORIES & CONSUMABLES MARKET FOR AMBULATORY INFUSION PUMPS, BY COUNTRY, 2019–2026 (USD MILLION) 133
6.3.1.6 PCA pumps 134
6.3.1.6.1 Increasing demand for pain management treatment is driving the adoption of PCA pump accessories & consumables 134
TABLE 34 DEDICATED ACCESSORIES & CONSUMABLES MARKET FOR PCA PUMPS,
BY COUNTRY, 2019–2026 (USD MILLION) 134
6.3.1.7 Implantable infusion pumps 135
6.3.1.7.1 Dedicated implantable infusion pump accessories are preferred because of their compatibility with the pumps 135
TABLE 35 DEDICATED ACCESSORIES & CONSUMABLES MARKET FOR IMPLANTABLE INFUSION PUMPS, BY COUNTRY, 2019–2026 (USD MILLION) 135
6.3.2 NON-DEDICATED ACCESSORIES & CONSUMABLES 136
TABLE 36 NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 136
TABLE 37 NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 137
6.3.2.1 Infusion catheters 137
6.3.2.1.1 Recurrent use of infusion catheters compared to other non-dedicated accessories & consumables to drive market growth 137
TABLE 38 NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET FOR INFUSION CATHETERS, BY COUNTRY, 2019–2026 (USD MILLION) 138
TABLE 39 NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET FOR INFUSION CATHETERS, BY COUNTRY, 2019–2026 (MILLION UNITS) 139
6.3.2.2 IV/administration sets 140
6.3.2.2.1 IV/administration sets are the primary requirement for infusion pumps—a key factor driving market growth 140
TABLE 40 NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET FOR IV/ADMINISTRATION SETS, BY COUNTRY, 2019–2026 (USD MILLION) 140
TABLE 41 NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET FOR IV/ADMINISTRATION SETS, BY COUNTRY, 2019–2026 (MILLION UNITS) 141
6.3.2.3 Needleless connectors 141
6.3.2.3.1 Needleless connectors are used to reduce bloodstream infection risks while providing infusions to patients 141
TABLE 42 NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET FOR NEEDLELESS CONNECTORS, BY COUNTRY, 2019–2026 (USD MILLION) 142
TABLE 43 NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET FOR NEEDLELESS CONNECTORS, BY COUNTRY, 2019–2026 (MILLION UNITS) 143
6.3.2.4 Cannulas 144
6.3.2.4.1 In terms of volume, the cannulas segment accounted for a major share of the non-dedicated accessories & consumables segment 144
 
TABLE 44 NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET FOR CANNULAS, BY COUNTRY, 2019–2026 (USD MILLION) 144
TABLE 45 NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET FOR CANNULAS, BY COUNTRY, 2019–2026 (MILLION UNITS) 145
6.3.2.5 Tubing & extension sets 145
6.3.2.5.1 Tubing & extension sets are used to provide a constant connection between a patient’s body and the infusion pump 145
TABLE 46 NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET FOR TUBING & EXTENSION SETS, BY COUNTRY, 2019–2026 (USD MILLION) 146
TABLE 47 NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET FOR TUBING & EXTENSION SETS, BY COUNTRY, 2019–2026 (MILLION UNITS) 147
6.3.2.6 Valves 147
6.3.2.6.1 Valves are used to regulate the flow of infusion fluids 147
TABLE 48 NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET FOR VALVES,
BY COUNTRY, 2019–2026 (USD MILLION) 148
TABLE 49 NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET FOR VALVES,
BY COUNTRY, 2019–2026 (MILLION UNITS) 149
6.3.2.7 Other non-dedicated accessories & consumables 150
TABLE 50 OTHER NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 150
6.4 DEVICES 151
6.4.1 DEVICES MARKET, BY PRODUCT 151
TABLE 51 INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 151
TABLE 52 INFUSION PUMP DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 152
TABLE 53 INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (THOUSAND UNITS) 152
6.4.1.1 Volumetric infusion pumps 153
6.4.1.1.1 Wide applications of volumetric infusion pumps to drive market growth 153
TABLE 54 VOLUMETRIC INFUSION PUMPS AVAILABLE IN THE MARKET 153
TABLE 55 VOLUMETRIC INFUSION PUMPS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 154
TABLE 56 VOLUMETRIC INFUSION PUMPS MARKET, BY COUNTRY,
2019–2026 (THOUSAND UNITS) 155
6.4.1.2 Insulin pumps 155
6.4.1.2.1 Market for insulin pumps is projected to grow at a significant CAGR during the forecast period 155
TABLE 57 INSULIN PUMPS AVAILABLE IN THE MARKET 156
TABLE 58 INSULIN PUMPS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 157
TABLE 59 INSULIN PUMPS MARKET, BY COUNTRY, 2019–2026 (THOUSAND UNITS) 158
6.4.1.3 Ambulatory infusion pumps 158
TABLE 60 AMBULATORY INFUSION PUMPS AVAILABLE IN THE MARKET 159
TABLE 61 AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2019–2026 (USD MILLION) 160
TABLE 62 AMBULATORY INFUSION PUMPS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 160
TABLE 63 AMBULATORY INFUSION PUMPS MARKET, BY COUNTRY,
2019–2026 (THOUSAND UNITS) 161
6.4.1.3.1 Disposable infusion pumps 161
6.4.1.3.1.1 Disposable infusion pumps are small, lightweight, and easy-to-operate—key factors driving market growth 161
TABLE 64 DISPOSABLE INFUSION PUMPS AVAILABLE IN THE MARKET 162
TABLE 65 DISPOSABLE INFUSION PUMPS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 162
6.4.1.3.2 Chemotherapy infusion pumps 163
6.4.1.3.2.1 Chemotherapy infusion pumps are designed to provide continuous infusion to cancer patients at home 163
TABLE 66 CHEMOTHERAPY INFUSION PUMPS AVAILABLE IN THE MARKET 163
TABLE 67 CHEMOTHERAPY INFUSION PUMPS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 164
6.4.1.4 Syringe infusion pumps 164
6.4.1.4.1 Syringe infusion pumps are used to deliver a lower volume of fluids at a low flow rate 164
TABLE 68 SYRINGE INFUSION PUMPS AVAILABLE IN THE MARKET 165
TABLE 69 SYRINGE INFUSION PUMPS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 166
TABLE 70 SYRINGE INFUSION PUMPS MARKET, BY COUNTRY,
2019–2026 (THOUSAND UNITS) 167
6.4.1.5 Enteral infusion pumps 167
6.4.1.5.1 Enteral infusion pumps are designed to deliver nutrients and medicines into the patient’s digestive tract 167
TABLE 71 ENTERAL INFUSION PUMPS AVAILABLE IN THE MARKET 168
TABLE 72 ENTERAL INFUSION PUMPS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 169
TABLE 73 ENTERAL INFUSION PUMPS MARKET, BY COUNTRY,
2019–2026 (THOUSAND UNITS) 170
6.4.1.6 PCA pumps 170
6.4.1.6.1 Growth in the pain management market is supporting the growth of the PCA pumps segment 170
TABLE 74 PCA PUMPS AVAILABLE IN THE MARKET 171
TABLE 75 PCA PUMPS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 172
TABLE 76 PCA PUMPS MARKET, BY COUNTRY, 2019–2026 (THOUSAND UNITS) 173
6.4.1.7 Implantable infusion pumps 173
6.4.1.7.1 Need for surgical intervention for the placement of pumps and the high cost of the procedure are hampering the adoption of implantable infusion pumps 173
TABLE 77 IMPLANTABLE INFUSION PUMPS AVAILABLE IN THE MARKET 174
TABLE 78 IMPLANTABLE INFUSION PUMPS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 174
TABLE 79 IMPLANTABLE INFUSION PUMPS MARKET, BY COUNTRY,
2019–2026 (THOUSAND UNITS) 175
6.4.2 DEVICES MARKET, BY TECHNOLOGY 175
TABLE 80 INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 175
6.4.2.1 Traditional infusion pumps 176
6.4.2.1.1 Wide applications of traditional infusion pumps due to their low cost to drive market growth 176
TABLE 81 TRADITIONAL INFUSION PUMPS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 176
6.4.2.2 Specialty infusion pumps 177
6.4.2.2.1 Technological advancements & rising adoption of specialty infusion pumps in home care settings to drive market growth 177
TABLE 82 SPECIALTY INFUSION PUMPS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 177
6.4.3 DEVICES MARKET, BY TYPE 178
TABLE 83 INFUSION PUMP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 178
6.4.3.1 Stationary infusion pumps 178
6.4.3.1.1 High adoption of stationary infusion pumps in hospitals to drive market growth 178
TABLE 84 STATIONARY INFUSION PUMPS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 179
6.4.3.2 Portable infusion pumps 180
6.4.3.2.1 Technological advancements in portable infusion pumps to drive market growth 180
TABLE 85 PORTABLE INFUSION PUMPS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 180
7 INFUSION PUMPS MARKET, BY APPLICATION 181
7.1 INTRODUCTION 182
TABLE 86 INFUSION PUMPS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 182
7.2 CHEMOTHERAPY/ONCOLOGY 183
7.2.1 GROWING GLOBAL INCIDENCE OF CANCER TO DRIVE THE DEMAND FOR INFUSION PUMPS FOR CHEMOTHERAPY 183
FIGURE 43 ESTIMATED NUMBER OF NEW CANCER CASES, BY REGION, 2012–2040 183
TABLE 87 INFUSION PUMPS MARKET FOR CHEMOTHERAPY/ONCOLOGY APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 184
7.3 DIABETES MANAGEMENT 184
7.3.1 HIGH PREVALENCE OF DIABETES HAS INCREASED THE DEMAND FOR ACCESSIBLE AND EFFECTIVE DIABETES MANAGEMENT—A KEY FACTOR DRIVING MARKET GROWTH 184
FIGURE 44 DIABETES INCIDENCE, BY COUNTRY, 2010–2030 185
TABLE 88 INFUSION PUMPS MARKET FOR DIABETES MANAGEMENT APPLICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION) 186
7.4 GASTROENTEROLOGY 187
7.4.1 DOCTORS PREFER TO TREAT PATIENTS WITH SEVERE DIGESTIVE SYSTEM DISORDERS BY USING INFUSION PUMPS TO DELIVER DRUGS INTO THE SYSTEM—A KEY FACTOR DRIVING MARKET GROWTH 187
TABLE 89 DISEASES & DISORDERS OF THE DIGESTIVE SYSTEM 187
FIGURE 45 DEATHS DUE TO GASTROINTESTINAL DISEASES, 1990–2017 188
TABLE 90 INFUSION PUMPS MARKET FOR GASTROENTEROLOGY APPLICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION) 189
7.5 ANALGESIA/PAIN MANAGEMENT 189
7.5.1 RISING NUMBER OF SURGICAL PROCEDURES TO PROPEL MARKET GROWTH 189
TABLE 91 CHRONIC PAIN STATISTICS, 2018 190
TABLE 92 INFUSION PUMPS MARKET FOR ANALGESIA/PAIN MANAGEMENT APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 191
7.6 PEDIATRICS/NEONATOLOGY 191
7.6.1 INCREASING INCIDENCE OF DIABETES IN PEDIATRIC PATIENTS IS DRIVING THE ADOPTION OF INFUSION PUMPS 191
TABLE 93 PEDIATRIC POPULATION WITH DIABETES, BY COUNTRY, 2015 VS. 2019 192
TABLE 94 INFUSION PUMPS MARKET FOR PEDIATRICS/NEONATOLOGY APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 193
7.7 HEMATOLOGY 193
7.7.1 INCREASING PREVALENCE OF BLOOD DISORDERS TO SUPPORT THE GROWTH OF THIS SEGMENT 193
TABLE 95 PREVALENCE OF ANEMIA IN WOMEN OF REPRODUCTIVE AGE (15–49 YEARS) (% OF THE POPULATION), BY COUNTRY 194
TABLE 96 INFUSION PUMPS MARKET FOR HEMATOLOGY APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 195
7.8 OTHER APPLICATIONS 195
TABLE 97 INFUSION PUMPS MARKET FOR OTHER APPLICATIONS, BY COUNTRY,
2019–2026 (USD MILLION) 196
8 INFUSION PUMPS MARKET, BY SETTING 197
8.1 INTRODUCTION 198
TABLE 98 INFUSION PUMPS MARKET, BY SETTING, 2019–2026 (USD MILLION) 198
8.2 HOSPITALS 198
8.2.1 STRONG FINANCIAL CAPABILITIES OF HOSPITALS FOR PURCHASING HIGH-PRICED INFUSION DEVICES TO DRIVE MARKET GROWTH 198
TABLE 99 NUMBER OF HOSPITALS, BY COUNTRY, 2010–2020 200
TABLE 100 INFUSION PUMPS MARKET FOR HOSPITALS, BY REGION,
2019–2026 (USD MILLION) 200
8.3 HOME CARE SETTINGS 201
8.3.1 DUE TO THE GROWING BURDEN OF NON-COMMUNICABLE DISEASES, PATIENTS ARE INCREASINGLY OPTING TO GET TREATED AT HOME—A KEY FACTOR DRIVING GROWTH IN THIS SEGMENT 201
TABLE 101 INFUSION PUMPS MARKET FOR HOME CARE SETTINGS,
2019–2026 (USD MILLION) 202
8.4 AMBULATORY CARE SETTINGS 202
8.4.1 GROWING NUMBER OF SURGICAL PROCEDURES PERFORMED IN ASCS TO DRIVE MARKET GROWTH 202
TABLE 102 INFUSION PUMPS MARKET FOR AMBULATORY CARE SETTINGS, BY COUNTRY, 2019–2026 (USD MILLION) 204
8.5 ACADEMIC & RESEARCH INSTITUTES 204
8.5.1 INCREASING MEDICAL RESEARCH ACTIVITIES TO SUPPORT THE GROWTH OF THIS SEGMENT 204
TABLE 103 INFUSION PUMPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY COUNTRY, 2019–2026 (USD MILLION) 205
9 INFUSION PUMPS MARKET, BY REGION 206
9.1 INTRODUCTION 207
FIGURE 46 INFUSION PUMPS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 207
TABLE 104 INFUSION PUMPS MARKET, BY REGION, 2019–2026 (USD MILLION) 208
9.2 COVID-19 IMPACT ON THE INFUSION PUMPS MARKET, BY REGION 208
9.3 NORTH AMERICA 209
FIGURE 47 NORTH AMERICA: INFUSION PUMPS MARKET SNAPSHOT 209
TABLE 105 NORTH AMERICA: INFUSION PUMPS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 210
TABLE 106 NORTH AMERICA: INFUSION PUMPS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 210
TABLE 107 NORTH AMERICA: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 210
TABLE 108 NORTH AMERICA: DEDICATED ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 211
TABLE 109 NORTH AMERICA: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 211
TABLE 110 NORTH AMERICA: INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 212
TABLE 111 NORTH AMERICA: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2019–2026 (USD MILLION) 212
TABLE 112 NORTH AMERICA: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 212
TABLE 113 NORTH AMERICA: INFUSION PUMP DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 213
TABLE 114 NORTH AMERICA: INFUSION PUMPS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 213
TABLE 115 NORTH AMERICA: INFUSION PUMPS MARKET, BY SETTING
2019–2026 (USD MILLION) 213
9.3.1 US 214
9.3.1.1 The US is expected to hold the leading position in the market due to the rising geriatric population, increasing prevalence of chronic diseases, and the growing home healthcare market 214
TABLE 116 KEY MACROINDICATORS FOR THE US 214
TABLE 117 US: INFUSION PUMPS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 215
TABLE 118 US: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 215
TABLE 119 US: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 215
TABLE 120 US: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 216
TABLE 121 US: INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 216
TABLE 122 US: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2019–2026 (USD MILLION) 217
TABLE 123 US: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 217
TABLE 124 US: INFUSION PUMP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 217
TABLE 125 US: INFUSION PUMPS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 218
TABLE 126 US: INFUSION PUMPS MARKET, BY SETTING, 2019–2026 (USD MILLION) 218
9.3.2 CANADA 218
9.3.2.1 Increasing incidence of chronic diseases to support the adoption of infusion pumps in Canada 218
TABLE 127 KEY MACROINDICATORS FOR CANADA 219
TABLE 128 CANADA: INFUSION PUMPS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 219
TABLE 129 CANADA: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 219
TABLE 130 CANADA: DEDICATED ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 220
TABLE 131 CANADA: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 220
TABLE 132 CANADA: INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 221
TABLE 133 CANADA: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2019–2026 (USD MILLION) 221
TABLE 134 CANADA: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 221
TABLE 135 CANADA: INFUSION PUMP DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 222
TABLE 136 CANADA: INFUSION PUMPS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 222
TABLE 137 CANADA: INFUSION PUMPS MARKET, BY SETTING,
2019–2026 (USD MILLION) 222
9.4 EUROPE 223
FIGURE 48 EUROPE: NUMBER OF CRITICAL BEDS PER 100,000 POPULATION 223
TABLE 138 EUROPE: INFUSION PUMPS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 224
TABLE 139 EUROPE: INFUSION PUMPS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 224
TABLE 140 EUROPE: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 225
TABLE 141 EUROPE: DEDICATED ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 225
TABLE 142 EUROPE: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 226
TABLE 143 EUROPE: INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 226
TABLE 144 EUROPE: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2019–2026 (USD MILLION) 227
TABLE 145 EUROPE: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 227
TABLE 146 EUROPE: INFUSION PUMP DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 227
TABLE 147 EUROPE: INFUSION PUMPS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 228
TABLE 148 EUROPE: INFUSION PUMPS MARKET, BY SETTING,
2019–2026 (USD MILLION) 228
9.4.1 GERMANY 228
9.4.1.1 Presence of leading infusion pump manufacturers to drive market growth in Germany 228
TABLE 149 KEY MACROINDICATORS FOR GERMANY 229
TABLE 150 GERMANY: INFUSION PUMPS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 230
TABLE 151 GERMANY: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 230
TABLE 152 GERMANY: DEDICATED ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 230
TABLE 153 GERMANY: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 231
TABLE 154 GERMANY: INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 231
TABLE 155 GERMANY: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2019–2026 (USD MILLION) 232
TABLE 156 GERMANY: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 232
TABLE 157 GERMANY: INFUSION PUMP DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 232
TABLE 158 GERMANY: INFUSION PUMPS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 233
TABLE 159 GERMANY: INFUSION PUMPS MARKET, BY SETTING,
2019–2026 (USD MILLION) 233
9.4.2 FRANCE 233
9.4.2.1 Well-established healthcare system to support market growth in France 233
TABLE 160 KEY MACROINDICATORS FOR FRANCE 234
TABLE 161 FRANCE: INFUSION PUMPS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 234
TABLE 162 FRANCE: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 235
TABLE 163 FRANCE: DEDICATED ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 235
TABLE 164 FRANCE: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 236
TABLE 165 FRANCE: INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 236
TABLE 166 FRANCE: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2019–2026 (USD MILLION) 237
TABLE 167 FRANCE: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 237
TABLE 168 FRANCE: INFUSION PUMP DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 237
TABLE 169 FRANCE: INFUSION PUMPS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 238
TABLE 170 FRANCE: INFUSION PUMPS MARKET, BY SETTING,
2019–2026 (USD MILLION) 238
9.4.3 UK 238
9.4.3.1 High burden of diabetes in the country to propel the growth of the infusion pumps market 238
TABLE 171 KEY MACROINDICATORS FOR THE UK 239
TABLE 172 UK: INFUSION PUMPS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 239
TABLE 173 UK: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 240
TABLE 174 UK: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 240
TABLE 175 UK: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 241
TABLE 176 UK: INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 241
TABLE 177 UK: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2019–2026 (USD MILLION) 242
TABLE 178 UK: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 242
TABLE 179 UK: INFUSION PUMP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 242
TABLE 180 UK: INFUSION PUMPS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 243
TABLE 181 UK: INFUSION PUMPS MARKET, BY SETTING, 2019–2026 (USD MILLION) 243
9.4.4 ITALY 243
9.4.4.1 Growing demand for cost-effective home care services to support market growth 243
TABLE 182 KEY MACROINDICATORS FOR ITALY 244
TABLE 183 ITALY: INFUSION PUMPS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 244
TABLE 184 ITALY: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 245
TABLE 185 ITALY: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 245
TABLE 186 ITALY: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 246
TABLE 187 ITALY: INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 246
TABLE 188 ITALY: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2019–2026 (USD MILLION) 247
TABLE 189 ITALY: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 247
TABLE 190 ITALY: INFUSION PUMP DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 247
TABLE 191 ITALY: INFUSION PUMPS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 248
TABLE 192 ITALY: INFUSION PUMPS MARKET, BY SETTING, 2019–2026 (USD MILLION) 248
9.4.5 SPAIN 248
9.4.5.1 Rising prevalence of cancer to support the market for infusion pumps in Spain 248
TABLE 193 KEY MACROINDICATORS FOR SPAIN 249
TABLE 194 SPAIN: INFUSION PUMPS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 249
TABLE 195 SPAIN: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 250
TABLE 196 SPAIN: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 250
TABLE 197 SPAIN: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 251
TABLE 198 SPAIN: INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 251
TABLE 199 SPAIN: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2019–2026 (USD MILLION) 252
TABLE 200 SPAIN: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 252
TABLE 201 SPAIN: INFUSION PUMP DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 252
TABLE 202 SPAIN: INFUSION PUMPS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 253
TABLE 203 SPAIN: INFUSION PUMPS MARKET, BY SETTING, 2019–2026 (USD MILLION) 253
9.4.6 REST OF EUROPE 253
TABLE 204 ROE: INFUSION PUMPS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 254
TABLE 205 ROE: INFUSION PUMP ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 254
TABLE 206 ROE: DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 255
TABLE 207 ROE: NON-DEDICATED ACCESSORIES & CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 255
TABLE 208 ROE: INFUSION PUMP DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 256
TABLE 209 ROE: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2019–2026 (USD MILLION) 256
TABLE 210 ROE: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 256
TABLE 211 ROE: INFUSION PUMP DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 257
TABLE 212 ROE: INFUSION PUMPS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 257
TABLE 213 ROE: INFUSION PUMPS MARKET, BY SETTING, 2019–2026 (USD MILLION) 257

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127